ask="N/A"
ask_size="N/A"
average_daily_volume="18848"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="-0.45"
change_from_200_day_moving_average="-0.03"
change_from_50_day_moving_average="-0.22"
change_from_52_week_high="-2.65"
change_From_52_week_low="2.20"
change_in_percent="-7.83%"
close="5.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.49"
eps_estimate_next_quarter="-0.11"
eps_estimate_next_year="-0.52"
ex_dividend_date="N/A"
float_shares="3450000"
high="6.00"
high_52_weeks="7.95"
last_trade_date="3/9/2017"
last_trade_price="5.30"
last_trade_size="100"
last_trade_time="4:01pm"
low="5.22"
low_52_weeks="3.10"
market_capitalization="152.16M"
moving_average_200_day="5.33"
moving_average_50_day="5.52"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="8.88"
open="5.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.65%"
percent_change_from_50_day_moving_average="-3.90%"
percent_change_from_52_week_high="-33.33%"
percent_change_from_52_week_low="+70.97%"
previous_close="5.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="13.01"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="2.98"
stock_exchange="ASE"
symbol="OCX"
volume="48783"
weeks_range_52="3.10 - 7.95"
